Related Experiment Videos
Update on tumor cell procoagulant factors.
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA., USA.
Acta Haematologica
|September 11, 2001
Summary
Tumor cells disrupt the body's natural blood clotting and clot-dissolving balance. This review examines how these cellular activities impact cancer growth, metastasis, and overall hemostasis.
Area of Science:
- Oncology
- Hematology
- Biochemistry
Background:
- Tumor cells release factors like tissue factor and cancer procoagulant.
- These factors interact with coagulation and fibrinolytic systems.
- This interaction disrupts normal hemostasis and cellular balance.
Purpose of the Study:
- To review recent findings on the interplay between cellular and hemostatic factors.
- To examine the role of these interactions in cancer progression.
- To understand the impact on vascular function and hemostasis.
Main Methods:
- Literature review of recent observations.
- Examination of molecular interactions.
- Analysis of protease and inhibitor roles.
Main Results:
- Tumor-derived factors significantly alter hemostatic balance.
- These alterations facilitate tumor cell growth and metastasis.
- Proteases and their inhibitors are key mediators in these processes.
Conclusions:
- The interaction between tumor cells and hemostatic systems is complex.
- This interaction is crucial for understanding cancer biology and treatment.
- Further research into these pathways can reveal therapeutic targets.